Iopidine

Known as: Iopimax 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2014
01219922014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
  • 2014
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination… (More)
  • table 1
Is this relevant?
2010
2010
CA SE PRE SENTATION In March 1995, a 32-year-old white female presented for initial consultation. The patient was in the third… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
Horner syndrome, manifested by ipsilateral miosis, upper lid ptosis, and sometimes facial anhidrosis, is caused by disruption of… (More)
  • figure 2
  • figure 2
Is this relevant?
Review
2005
Review
2005
A side effect of the injection of botulinum toxin into the upper third of the face is ptosis or lid droop. A therapy recommended… (More)
Is this relevant?
2003
2003
PURPOSE To expand on current theories concerning the vitreal-induced mechanism underlying the development of foveolar… (More)
Is this relevant?
2001
2001
Iopidine is an a 2 agonist with a few indications in glaucoma treatment. 48 patients with medically uncontrolled POAG and PACG… (More)
Is this relevant?
1999
1999
In the present study the effects of beta-adrenergic antagonist and alpha-adrenergic agonist drugs on rabbit corneas were… (More)
Is this relevant?
1995
1995
• Background: This pilot study evaluated the acute effects of topical ocular apraclonidine 1% (Iopidine) in 10 patients with… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1992
1992
A randomized, masked study measuring postoperative intraocular pressure at 4, 8, and 24 hours, two to seven days, and one month… (More)
Is this relevant?